Evidence-Based Medicine Guidelines
Photodynamic therapy for neovascular age-related macular degeneration
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Photodynamic Therapy for Neovascular Age-related Macular Degeneration." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456713/all/Photodynamic_therapy_for_neovascular_age_related_macular_degeneration.
Photodynamic therapy for neovascular age-related macular degeneration. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/456713/all/Photodynamic_therapy_for_neovascular_age_related_macular_degeneration. Accessed March 4, 2025.
Photodynamic therapy for neovascular age-related macular degeneration. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/456713/all/Photodynamic_therapy_for_neovascular_age_related_macular_degeneration
Photodynamic Therapy for Neovascular Age-related Macular Degeneration [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456713/all/Photodynamic_therapy_for_neovascular_age_related_macular_degeneration.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Photodynamic therapy for neovascular age-related macular degeneration
ID - 456713
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456713/all/Photodynamic_therapy_for_neovascular_age_related_macular_degeneration
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
